Am. Udayakumar et Mk. Bhargava, PERSISTENCE OF CHROMOSOMAL-ABERRATIONS IN BLOOD-LYMPHOCYTES 11 YEARS AFTER CESSATION OF CMF THERAPY IN A BREAST-CANCER PATIENT, Cancer letters, 107(1), 1996, pp. 1-3
Chromosomal aberrations were examined in a breast cancer patient 11 ye
ars after cessation of cyclophosphamide methotraxate and 5-fluorouraci
l (CMF) therapy. This indicates that they may well be derived from a p
opulation of genetically damaged progenitor cells, from which abnormal
and possibly malignant cell clones may have been generated, and a fra
ction of these randomly occurring chromosome rearrangements appear to
be 'stable'.